Michigan Biomedical Venture Fund (MBVF) invests in and supports University of Michigan life science startup companies, including therapeutics, medical devices, diagnostics, and health IT. Follow us for updates on U-M startups, venture capital, and medical innovation. Founded based on an initial gift from the Monroe-Brown Foundation, MBVF makes seed-stage investments and provides support to help companies reach key milestones and attract additional investors. This evergreen fund serves to strengthen the critical pipeline between research and the biomedical innovation life cycle, create broad clinical and economic impact through startups, and continue to attract world-class talent to U-M’s entrepreneurial ecosystem. This fund is exclusively for biomedical startups with U-M IP / license. Most applicants need to complete a translational program (including Coulter, MTRAC, NSF I-Corps). MBVF is a collaborative effort between the U-M College of Engineering’s Center for Entrepreneurship (CFE) and U-M Medical School’s Fast Forward Medical Innovation (FFMI).